Atrial fibrillation after cardiac surgery

Annals of Internal Medicine

Volumn 135, Issue 12, 2001, Pages 1061-1073

  Maisel, W H ^a   Rawn, J D ^a   Stevenson, W G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ALGORITHM; ANTICOAGULATION; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0035909841     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-12-200112180-00010     Document Type: Review

References (104)

1. Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification
2. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources
3. Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization
4. Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment
5. Prevention of supravenrricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials
6. Atrial fibrillation after cardiac surgery: A major morbid event?
7. Right coronary artery stenosis: An independent predictor of atrial fibrillation after coronary artery bypass surgery
8. Risk factors for atrial fibrillation after coronary artery bypass grafting
9. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass
10. The importance of age as a predictor of atrial fibrillation and flutter after coronary, artery bypass grafting
11. Hazards of postoperative atrial arrthymias
12. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation
13. Verapamil prophylaxis for postoperative atrial dysrhythmias: A prospective, randomized, double-blind study using drug level monitoring
14. Atrial tachyarrhythmias after cardiac surgery: Results of disopyramide therapy
15. Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables
16. Atrial ectopic activity and atrial fibrillation/flutter after coronary artery bypass surgery. A case-base study controlling for confounding from age, beta-blocker treatment, and time distance from operation
17. Peri-operative supraventricular arthythmias in coronary bypass surgery
18. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations
19. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly?
20. Digoxin and propranolol in the prophylaxis of supraventricular tachydysrhythmias after coronary artery bypass surgery
21. Oral verapamii for prophylaxis of supraventricular tachycardia after myocardial revascularization. A randomized trial
22. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: A randomized, double-blind trial
23. Supraventricular tachyarrhythmias after myocardial revascularization: A randomized trial of prophylactic digitalization
24. Atrial arrhythmias after cardiothoracic surgery
25. Atrial fibrillation after coronary, artery bypass surgery: A model for preoperative risk stratification
26. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations
27. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
28. Premature atrial beat eliciting atrial fibrillation after coronary artery bypass grafting
29. The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart
30. A perspective of postoperative atrial fibrillation in cardiac operations
31. Supraventricular conduction abnormalities following cardiac operations. A complication of inadequate atrial preservation
32. Electrical behavior of the heart following high-potassium cardioplegia
33. Internal cardiac cooling improves atrial preservation: Electrophysiological and biochemical assessment
34. Persistent atrial activity during cardioplegic arrest: A possible factor in the etiology of postoperative supraventricular tachyarrhythmias
35. Atrial activity during cardioplegia and postoperative arrhythmias
36. Stroke following coronary-artery bypass surgery. A case-control estimate of the risk from carotid bruits
37. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting
38. Hemodynamics and echocardiograms before and after cardioversion of atrial fibrillation to normal sinus rhythm
39. Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery
40. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
41. Pathology of atrial fibrillation in man
42. Does the type of venous drainage or cardioplegia affect postoperative conduction and atrial arthythmias?
43. Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting
44. Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting
45. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery
46. Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: A prospective, double-blind, randomized, placebo-controlled pilot study
47. Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: A prospective trial
48. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: A randomized open trial
49. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarthythmias early after coronary artery bypass operations
50. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery
51. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting
52. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: A prospective, double-blind, randomized, placebo-controlled study
53. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol
54. Oral d,1 sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study
55. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: Results of a prospective, placebo-controlled study
56. Amiodarone prophylaxis for tachycardias after coronary artery surgery: A randomised, double blind, placebo controlled trial
57. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
58. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The Amiodarone Reduction in Coronary Heart (ARCH) trial
59. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery
60. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting
61. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery
62. Incidence and prevention of supraventricular tachyarrthythmias after coronary bypass surgery
63. Efficacy and safety, of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery
64. Propranolol for prevention of postoperative cardiac arrhythmias: A randomized study
65. Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. A randomized trial
66. Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery
67. Amiodarone
68. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting
69. Magnesium substitution in elective coronary artery surgery: A double-blind clinical study
70. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
71. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention
72. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery
73. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery
74. Atrial pacing for the prevention of postoperative atrial fibrillation: How and where to pace?
75. Ineffectiveness and potential proarrhythmia of atrial pacing for atrial fibrillation prevention after coronary artery bypass grafting
76. Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery
77. Epicardial, biatrial synchronous pacing for prevention of atrial fibrillation after cardiac surgery
78. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery
79. Treatment of atrial arrhythmias after cardiac surgery with intravenous disopyramide
80. A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery
81. Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital
82. Proarrhythmia
83. Comparison of propafenone versus ptocainamide for the acute treatment of atrial fibrillation after cardiac surgery
84. Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery
85. Efficacy of flecainide acetate for atrial arrhythmias following coronary artery bypass grafting
86. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial
87. Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrthythmias after cardiopulmonary bypass
88. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations
89. Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations
90. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery
91. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: A meta-analysis
92. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
93. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
94. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
95. Dofetilide in patients with congestive heart failure and left ventricular dysfunction
96. Final results
97. Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: A prospective, randomized study
98. Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion
99. The role of antico-agulation in the development of pericardial effusion and late tamponade after cardiac surgery
100. Management of patients with atrial fibrillation. A Statement for Health-care Professionals
101. Cost-effective management of acute atrial fibrillation: Role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy
102. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
103. Recurrent atrial arrhythmias following treatment for postoperative atrial fibrillation after coronary bypass operations
104. Long-term prevention of atrial fibrillation after coronary artery bypass surgery: Comparison of quinidine, verapamil, and amiodarone in mainraining sinus rhythm